YCT529
Подписчиков: 0, рейтинг: 0
| Identifiers | |
|---|---|
| |
| PubChem CID | |
| Chemical and physical data | |
| Formula | C29H25NO3 |
| Molar mass | 435.523 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
YCT529 is a drug which acts as a potent and selective antagonist of the Vitamin A receptor retinoic acid receptor alpha (RAR-α). In studies on mice it produced a 99% reduction in sperm production, and it has proceeded to early stage human clinical trials as a potential male contraceptive.